Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 5/20 | 0.79 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.79 |
| ▸ | USP2 | O75604 | 1/20 | 0.79 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.79 |
| ▸ | HPGD | P15428 | 1/20 | 0.79 |
| ▸ | FAP | Q12884 | 1/20 | 0.79 |
| ▸ | NR1I2 | O75469 | 5/20 | 0.66 |
| ▸ | HTR2C | P28335 | 1/20 | 0.66 |
| ▸ | PPARG | P37231 | 2/20 | 0.64 |
| ▸ | SLC22A6 | Q4U2R8 | 2/20 | 0.64 |
| ▸ | SLC22A8 | Q8TCC7 | 2/20 | 0.64 |
| ▸ | SLC22A11 | Q9NSA0 | 2/20 | 0.64 |
| ▸ | ALB | P02768 | 1/20 | 0.64 |
| ▸ | TDP1 | Q9NUW8 | 6/20 | 0.63 |
| ▸ | APEX1 | P27695 | 3/20 | 0.63 |
| ▸ | APAF1 | O14727 | 2/20 | 0.63 |
| ▸ | LMNA | P02545 | 2/20 | 0.63 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.63 |
| ▸ | TSHR | P16473 | 1/20 | 0.63 |
| ▸ | PLCG1 | P19174 | 1/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cefditoren SCHEMBL27465513 | 1.00 | MAPT (0.79) | MAPTALDH1A1USP2CYP3A4HPGD | |
| Cefditoren SCHEMBL16072829 | 1.00 | MAPT (0.79) | MAPTALDH1A1USP2CYP3A4HPGD | |
| Cefditoren SCHEMBL27465514 | 1.00 | MAPT (0.79) | MAPTALDH1A1USP2CYP3A4HPGD | |
| Cefditoren SCHEMBL157719 | 1.00 | MAPT (0.79) | MAPTALDH1A1USP2CYP3A4HPGD | |
| Cefditoren SCHEMBL37473 | 1.00 | MAPT (0.79) | MAPTALDH1A1USP2CYP3A4HPGD | |
| Cefditoren SCHEMBL2925672 | 1.00 | MAPT (0.79) | MAPTALDH1A1USP2CYP3A4HPGD | |
| Cefditoren SCHEMBL183495 | 1.00 | MAPT (0.79) | MAPTALDH1A1USP2CYP3A4HPGD | |
| Cefditoren SCHEMBL13986532 | 1.00 | MAPT (0.79) | MAPTALDH1A1USP2CYP3A4HPGD | |
| Cefditoren SCHEMBL1650584 | 1.00 | MAPT (0.79) | MAPTALDH1A1USP2CYP3A4HPGD | |
| Cefditoren SCHEMBL1650656 | 0.99 | MAPT (0.78) | MAPTALDH1A1USP2CYP3A4HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0236231-B1 | Novel cephem compounds | MEIJI SEIKA KAISHA (JP) | 1994-05-04 | — | — | EP | claimed |
| EP-0175610-B1 | NEW CEPHALOSPORIN COMPOUNDS AND THE PRODUCTION THEREOF | MEIJI SEIKA KAISHA LTD. (JP) | 1990-08-29 | — | — | EP | claimed |
| US-4839350-A | Cephalosporin compounds and the production thereof | MEIJI SEIKA KAISHA, LTD. (JP) | 1989-06-13 | — | — | US | claimed |
| EP-0175610-A2 | New cephalosporin compounds and the production thereof | MEIJI SEIKA KAISHA LTD. (JP) | 1986-03-26 | — | — | EP | claimed |
| US-8648065-B2 | Antibacterial medicinal composition of enhanced oral absorptivity | MEIJI SEIKA PHARMA CO., LTD. (JP) | 2014-02-11 | — | — | US | disclosed |
| EP-1051978-B1 | CRYSTALLOGRAPHICALLY STABLE AMORPHOUS CEPHALOSPORIN COMPOSITIONS AND PROCESS FOR PRODUCING THE SAME | MEIJI SEIKA PHARMA CO LTD (JP) | 2012-08-22 | — | — | EP | disclosed |
| EP-1671635-B1 | NONCRYSTALLINE ANTIBACTERIAL COMPOSITION CONTAINING CEFDITOREN PIVOXIL | MEIJI SEIKA PHARMA CO LTD (JP) | 2012-01-04 | — | — | EP | disclosed |
| EP-1555024-B1 | ANTIBACTERIAL MEDICINAL COMPOSITION OF ENHANCED ORAL ABSORPTIVITY | MEIJI SEIKA KAISHA (JP) | 2010-09-29 | — | — | EP | disclosed |
| US-20080069879-A1 | STABLE SOLID DOSAGE FORM CONTAINING AMORPHOUS CEFDITOREN PIVOXIL AND PROCESS FOR PREPARATION THEREOF | RANBAXY LABORATORIES LIMITED (IN) | 2008-03-20 | — | — | US | disclosed |
| US-20070053973-A1 | Amorphous antibiotic composition comprising cefditoren pivoxil | MEIJI SEIKA KAISHA, LTD. (JP) | 2007-03-08 | — | — | US | disclosed |
| EP-1671635-A1 | NONCRYSTALLINE ANTIBACTERIAL COMPOSITION CONTAINING CEFDITOREN PIVOXIL | MEIJI SEIKA KAISHA LTD. (JP) | 2006-06-21 | — | — | EP | disclosed |
| US-20060051411-A1 | Antibacterial medicinal composition of enhanced oral absorptivity | MEIJI SEIKA PHARMA CO., LTD. (JP) | 2006-03-09 | — | — | US | disclosed |
| EP-1016665-A1 | PROCESS FOR THE SELECTIVE PREPARATION OF Z-ISOMERS OF 3-(2-SUBSTITUTED VINYL)CEPHALOSPORINS | Meiji Seika Kaisha, Ltd. (JP) | 2000-07-05 | — | — | EP | disclosed |
| EP-0723965-A1 | NOVEL CEPHALOSPORIN DERIVATIVE | MEIJI SEIKA KAISHA LTD. (JP) | 1996-07-31 | — | — | EP | disclosed |
| EP-0236231-B1 | Novel cephem compounds | MEIJI SEIKA KAISHA (JP) | 1994-05-04 | — | — | EP | disclosed |
| EP-0175610-B1 | NEW CEPHALOSPORIN COMPOUNDS AND THE PRODUCTION THEREOF | MEIJI SEIKA KAISHA LTD. (JP) | 1990-08-29 | — | — | EP | disclosed |
| US-4918068-A | ACTIVE AGAINST GRAM POSITIVE BACTERIA | MEIJI SEIKA KAISHA, LTD. (JP) | 1990-04-17 | — | — | US | disclosed |
| US-4839350-A | Cephalosporin compounds and the production thereof | MEIJI SEIKA KAISHA, LTD. (JP) | 1989-06-13 | — | — | US | disclosed |
| EP-0236231-A2 | Novel cephem compounds | MEIJI SEIKA KAISHA LTD. (JP) | 1987-09-09 | — | — | EP | disclosed |
| EP-0175610-A2 | New cephalosporin compounds and the production thereof | MEIJI SEIKA KAISHA LTD. (JP) | 1986-03-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060051411-A1 | Antibacterial medicinal composition of enhanced oral absorptivity | SI, SLC10A2, ELOVL6 | MAPT 2773/4885ALDH1A1 3542/4885USP2 1780/4885 |
| US-20070053973-A1 | Amorphous antibiotic composition comprising cefditoren pivoxil | CFD, PEPD, PEF1 | MAPT 2041/4885ALDH1A1 3635/4885USP2 886/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.